Français
ItalianoBond Bristol Myers Squibb 3.95% ( US110122CT39 ) in USD
| Issuer | Bristol Myers Squibb | ||||||||
| Market price | 100.00 % ⇌ | ||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US110122CT39 ( in USD )
|
||||||||
| Interest rate | 3.95% per year ( payment 2 times a year) | ||||||||
| Maturity | 15/10/2020 - Bond has expired | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | 2 000 USD | ||||||||
| Total amount | 425 282 000 USD | ||||||||
| Cusip | 110122CT3 | ||||||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb's US$425,282,000 3.95% bond (CUSIP: 110122CT3, ISIN: US110122CT39), issued in USD, matured on October 15, 2020, and has been redeemed at 100% of face value. |
||||||||
| |||||||||